The Deal
Sunday, November 8, 
5:20 am

The way they see it

Posted on August 15, 2007 at 7:45 PM
Filed under: 2007 | Counterparties | Cover Story | July-Aug. 2007 | The Magazine
Tagged: , , , , , , , , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]

TelescopesAug2007.jpgSoon we'll see the New Yorker cartoon. A chic young businesswoman, presumably an associate at a private equity firm, will be telling her unhappy boyfriend over martinis: "I thought we were covenant-lite!" The cartoon will appear, of course, amid strains in the secondary market for buyout loans of that description and as Congress pursues its plans to hike the tax rate on the type of income that made Blackstone's Steve Schwarzman rich enough to hire Rod Stewart to sing at his birthday party.

But filter out (if you can) some of the current noise around the private equity phenomenon, and ignore for the moment the compelling question of where we are in the M&A cycle. With a noisy initial public offering for Blackstone Group LP, another one pending for Kohlberg Kravis Roberts & Co. and a 35% share of deal activity in the record-setting first half of 2007, the PE business looks mighty frothy. Yet this is also an industry that has been decades in the making, and has brought about major and enduring changes in the way businesses are bought, sold and owned.

By now, most corporate dealmakers have had the experience of selling to PE firms, buying from them, or both. In most industries they've competed with them for assets. Still, many don't know private equity in a depth befitting its significance in the deal world. So even if a contraction in the debt markets should restore a bit of the edge corporates traditionally enjoyed over PE firms, there are obvious benefits to studying the way PE shops do the things they do, and trying to see the world through their eyes.

For help on that front we turn to the most authoritative source around: Our parent publication, The Deal. Over the past year, The Deal newsweekly has produced a series of landmark articles showing in depth what's really going on in PE land. You'll find three of them, in slightly modified form, beginning on page 18. Taken together they provide a sophisticated look at how PE firms transform companies, how they use (and sometimes overuse) debt, and how they compensate--and motivate--the executives that run their companies.

Before we get to those articles, though, some agenda setting is in order. For corporate development folks, is studying the private equity playbook largely a matter of knowing your competitor, the better to outmaneuver him? Or is it more about learning from your counterparty and perhaps finding ways to work together occasionally? Conversations with a couple of dealmakers who have worked on both sides of the fence--Dan Salliotte, vice president for strategy and business development at Idex Corp., and Dan Pryor, managing director at the Carlyle Group--indicate that it's a little of both.

Salliotte joined Northbrook, Ill.-based Idex, a diversified engineered products company with about $1.1 billion in sales, in 2004. He previously spent a couple of years with Oxford Investment Group, a middle-market private equity firm in Detroit, and before that worked in corporate development for manufacturer SPX Corp. Pryor, meanwhile, joined Washington-based Carlyle in 2005, having previously worked as vice president, strategic development, at Danaher Corp.

The two know each other and in their current roles have discussed collaborating on deals, though nothing has come together yet. The relationship came about because acquisition-minded Idex, a former KKR portfolio company (it's now public), is led by former Danaher exec Lawrence Kingsley. All of which may help to explain why, when comparing the strategic and PE approaches to dealmaking in separate interviews, Salliotte and Pryor found plenty of common ground.

As Pryor puts it: "Increasingly, I don't think there is a difference. I think that there are best-in-class practices that anybody can use."

One of those best practices has to do with the way acquirers size up a target and the market it serves. This is an area where a strategic buyer's strength--familiarity with the market--can also be a weakness. When he was a corporate dealmaker, Pryor says, "there were situations where we bought a business taking for granted some basic understandings of the industry and then had them proved wrong." Financial buyers, he says, "may look at things with fresh eyes because they're outsiders to the industry."

Yet as Salliotte can attest, there's no reason strategic buyers can't do the same kind of homework many financial buyers favor. That, in fact, is what Idex did in its January acquisition of Quadro Engineering LP, a small Canadian provider of particle-control solutions for the pharma market. "We knew the Quadro space," Salliotte says. "But we went out and found experts on the trends and characteristics of that market to confirm what we were hearing from the Quadro team." Salliotte says you don't see as much of that kind of research on the corporate side. But that may change. Gerson Lehrman Group, the New York consulting firm Idex used to find the experts, is expanding beyond its core private equity clients to work more with corporates.

Of course, business managers who know a field are more fundamentally an advantage for strategic buyers. At Idex, Salliotte runs a monthly process where he asks each of the company's 15 business units to identify logical targets. "We've got 15 management teams that can easily come up with 20 or 30 targets apiece," he says, "so we start with a large set of initial acquisition candidates that have a fair amount of business logic behind them." In get-acquainted meetings with acquisition candidates, the business unit executives bring credibility as they clearly lay out the strategic rationale for a deal.

Here the best practice flows the other way, since bigger PE firms can do something similar through their portfolio companies. In general, though, the deployment of business managers is a key point of differentiation between financial and strategic acquirers--and a source of advantage corporate dealmakers may underestimate.

The PE firms' emphasis on attracting and rewarding executives is the flip side of a vulnerability. "In a private equity diligence," says Pryor, "looking at management is much more important. Because if the CEO's a dud, I've got to figure out a solution to that before I buy the business. As a strategic buyer, you care about management, but it's not your paramount consideration, because you probably have some people you can use as backups."

The way they finance deals is another obvious difference between the two sides. But here again its significance may be underappreciated by corporate buyers--especially in middle-market transactions, which are often harder to finance than bigger ones. In Salliotte's view, corporate dealmakers are getting more knowledgeable about the models that PE competitors employ. To really gauge where a bid from a financial rival is likely to come in, though,you need to stay current on the debt markets (senior, mezzanine, second-lien) that a rival is tapping.

"Some of the rules that corporate development people apply are still too general," Salliotte says. "You really have to figure out specifically, for every property, the amount and terms of the debt structure that a private equity bidder will realistically be able to secure." Salliotte factors in a host of other variables as well: the amount of equity the PE bidder will be willing to put up; the percentage of equity proceeds upon exit required by mezzanine lenders or the management team; the likely entry and exit transaction multiples that financial sponsors are assuming; plus the minimum internal-rate-of-return parameters the sponsors are likely targeting.

Clearly, corporate and financial dealmakers can compete more effectively against each other by learning more about each other. A more complicated question is whether mutual understanding will give rise to more collaborations. According to both Pryor and Salliotte, partnering is an interesting idea that's tough to execute.

Pryor lists five kinds of deals that a strategic and a financial buyer might work together on: a spinoff from a strategic to a PE buyer, with the strategic retaining a stake; a partnership to carve up a business; a partnership whereby a financial buyer would warehouse and improve an asset, for later sale to a strategic; a partial-stake, capital-infusion deal such as Kohlberg Kravis Roberts' investment in Sun Microsystems Inc. in January (see box); and a transaction where a strategic folds a business unit into a company that a PE firm is buying in exchange for an equity stake in the new entity.

Aside from spinoffs, which are common, Pryor says all have considerable complexities. In a carve-up, for example, the fact that one partner must be the initial buyer and then on-sell some of the assets creates unwanted tax burdens as well as complications with the representations and warranties in the sales agreement. Collaborations remain an interest for Pryor, given his corporate background. But in general, he says, "I'm not sure you're going to see a lot more partnerships."

Would a big change in the financing markets alter the dynamic? We'll have to wait and see. But for the rest of this cycle and long into future ones, a few points will remain fixed. "We're all trying to buy companies," says Pryor, "but we're doing it for different reasons, and we have different financial measurements. There are some very good acquirers in the world and some very bad acquirers in the world. Some of the great acquirers are corporations, and some of the great acquirers are PE firms." - Kenneth Klee


A new kind of private equity deal in the tech industry

Under new management and on the mend following a prolonged period of difficulty, computer hardware maker Sun Microsystems Inc. has plenty of cash and little in common with struggling handset maker Palm Inc.

But both companies recently employed a new and unconventional approach to raising money from private equity investors: a so-called PIPE deal, or private investment in a public entity. While the terms and purposes of the transactions are different, they both point to the same broader trend: private equity firms seeking innovative ways to put their huge piles of capital to work.

The move by Palm, maker of the Treo, came in June after months of efforts to sell the company as a whole. Instead, Palm sold a 25% stake in its business to Elevation Partners for $325 million. The company also announced that former Apple Inc. executive Jon Rubenstein would come in as executive chairman and try to lead a turnaround

Sun announced its PIPE in January. It took the form of $700 million in convertible senior notes purchased by KKR Private Equity Investors LP, the Amsterdam-listed unit of Kohlberg Kravis Roberts & Co. As Sun CEO Jonathan Schwartz put it on his blog, "They loan us money at an extremely low interest rate, in exchange for the right to buy our shares if they rise above 25% of their original price."

If Palm's deal represented a bet by Elevation on a turnaround, Sun's was an endorsement by KKR of the company's current course. Bret Schaefer, Sun's vice president of shareholder value finance, says that Schwartz (who took over as CEO from Scott McNealy in 2006) pushed to do the deal largely to signal to Wall Street that Sun is as serious about its finances as it is about developing groundbreaking technology.

"KKR is very well respected and a fairly hard-nosed investor, and the idea of someone of that ilk investing in Sun sends a strong message," Schaefer says. "Perception is a huge part of this."

How will Sun use the money? Acquisitions are one possibility. The company's last big deal was the 2005 purchase of Storage Technology Corp. for $4.1 billion. At the time of the PIPE, KKR's George Roberts cited Sun's "substantial growth potential," and Schwartz said his company would use the proceeds to pursue "strategic opportunities for growth."

A complete buyout, it seems, is out of the question, since KKR signed a standstill agreement. The PE firm also took a board seat, and Schwartz says he's looking forward to introductions that could help Sun sell to KKR portfolio companies.

Craig Norris, who worked on the deal as Sun's vice president of corporate law, says he thinks it's likely that more deals of this sort will get done in the future. "I think private equity firms are looking for other ways to spend their money," he says. -- Andrea Orr



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Linklaters' Schmidt on Pfizer-Wyeth review

Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.